Literature DB >> 16284748

Gene expression profiling in skeletal muscle of Zucker diabetic fatty rats: implications for a role of stearoyl-CoA desaturase 1 in insulin resistance.

M D Voss1, A Beha, N Tennagels, G Tschank, A W Herling, M Quint, M Gerl, C Metz-Weidmann, G Haun, M Korn.   

Abstract

AIMS/HYPOTHESIS: Insulin resistance in skeletal muscle is a hallmark of type 2 diabetes. Therefore, we sought to identify and validate genes involved in the development of insulin resistance in skeletal muscle. MATERIALS: Differentially regulated genes in skeletal muscle of male obese insulin-resistant, and lean insulin-sensitive Zucker diabetic fatty (ZDF) rats were determined using Affymetrix microarrays. Based on these data, various aspects of glucose disposal, insulin signalling and fatty acid composition were analysed in a muscle cell line overexpressing stearoyl-CoA desaturase 1 (SCD1).
RESULTS: Gene expression profiling in insulin-resistant skeletal muscle revealed the most pronounced changes in gene expression for genes involved in lipid metabolism. Among these, Scd1 showed increased expression in insulin-resistant animals, correlating with increased amounts of palmitoleoyl-CoA. This was further investigated in a muscle cell line that overexpressed SCD1 and accumulated lipids, revealing impairments of glucose uptake and of different steps of the insulin signalling cascade. We also observed differential effects of high-glucose and fatty acid treatment on glucose uptake and long-chain fatty acyl-CoA profiles, and in particular an accumulation of palmitoleoyl-CoA in cells overexpressing SCD1. CONCLUSIONS/
INTERPRETATION: Insulin-resistant skeletal muscle of ZDF rats is characterised by a specific gene expression profile with increased levels of Scd1. An insulin-resistant phenotype similar to that obtained by treatment with palmitate and high glucose can be induced in vitro by overexpression of SCD1 in muscle cells. This supports the hypothesis that elevated SCD1 expression is a possible cause of insulin resistance and type 2 diabetes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16284748     DOI: 10.1007/s00125-005-0025-2

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  34 in total

1.  Glucose induces expression of stearoyl-CoA desaturase in 3T3-L1 adipocytes.

Authors:  B H Jones; M K Standridge; K J Claycombe; P J Smith; N Moustaïd-Moussa
Journal:  Biochem J       Date:  1998-10-15       Impact factor: 3.857

2.  GLUT4 translocation by insulin in intact muscle cells: detection by a fast and quantitative assay.

Authors:  Q Wang; Z Khayat; K Kishi; Y Ebina; A Klip
Journal:  FEBS Lett       Date:  1998-05-08       Impact factor: 4.124

3.  Dietary cholesterol and the activity of stearoyl CoA desaturase in rats: evidence for an indirect regulatory effect.

Authors:  J M Landau; A Sekowski; M W Hamm
Journal:  Biochim Biophys Acta       Date:  1997-04-21

4.  Interaction between growth hormone and insulin in the regulation of lipoprotein metabolism in the rat.

Authors:  Fredrik Frick; Daniel Lindén; Caroline Améen; Staffan Edén; Agneta Mode; Jan Oscarsson
Journal:  Am J Physiol Endocrinol Metab       Date:  2002-11       Impact factor: 4.310

5.  Loss of stearoyl-CoA desaturase-1 function protects mice against adiposity.

Authors:  James M Ntambi; Makoto Miyazaki; Jonathan P Stoehr; Hong Lan; Christina M Kendziorski; Brian S Yandell; Yang Song; Paul Cohen; Jeffrey M Friedman; Alan D Attie
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-12       Impact factor: 11.205

6.  Desaturation and elongation of Fatty acids and insulin action.

Authors:  B Vessby; I-B Gustafsson; S Tengblad; M Boberg; A Andersson
Journal:  Ann N Y Acad Sci       Date:  2002-06       Impact factor: 5.691

7.  Role for stearoyl-CoA desaturase-1 in leptin-mediated weight loss.

Authors:  Paul Cohen; Makoto Miyazaki; Nicholas D Socci; Aaron Hagge-Greenberg; Wolfgang Liedtke; Alexander A Soukas; Ratnendra Sharma; Lisa C Hudgins; James M Ntambi; Jeffrey M Friedman
Journal:  Science       Date:  2002-07-12       Impact factor: 47.728

8.  Peroxisome proliferators induce mouse liver stearoyl-CoA desaturase 1 gene expression.

Authors:  C W Miller; J M Ntambi
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

9.  Intramyocellular lipid and insulin resistance: a longitudinal in vivo 1H-spectroscopic study in Zucker diabetic fatty rats.

Authors:  Johanna Kuhlmann; Claudia Neumann-Haefelin; Ulrich Belz; Jürgen Kalisch; Hans-Paul Juretschke; Marion Stein; Elke Kleinschmidt; Werner Kramer; Andreas W Herling
Journal:  Diabetes       Date:  2003-01       Impact factor: 9.461

10.  GECKO: a complete large-scale gene expression analysis platform.

Authors:  Joachim Theilhaber; Anatoly Ulyanov; Anish Malanthara; Jack Cole; Dapeng Xu; Robert Nahf; Michael Heuer; Christoph Brockel; Steven Bushnell
Journal:  BMC Bioinformatics       Date:  2004-12-10       Impact factor: 3.169

View more
  18 in total

1.  CD36-dependent regulation of muscle FoxO1 and PDK4 in the PPAR delta/beta-mediated adaptation to metabolic stress.

Authors:  Zaher Nahlé; Michael Hsieh; Terri Pietka; Chris T Coburn; Paul A Grimaldi; Michael Q Zhang; Debopriya Das; Nada A Abumrad
Journal:  J Biol Chem       Date:  2008-02-28       Impact factor: 5.157

2.  AVE8134, a novel potent PPARα agonist, improves lipid profile and glucose metabolism in dyslipidemic mice and type 2 diabetic rats.

Authors:  Hans Ludwig Schäfer; Wolfgang Linz; Eugen Falk; Maike Glien; Heiner Glombik; Marcus Korn; Wolfgang Wendler; Andreas W Herling; Hartmut Rütten
Journal:  Acta Pharmacol Sin       Date:  2012-01       Impact factor: 6.150

3.  Stearoyl CoA desaturase 1 is elevated in obesity but protects against fatty acid-induced skeletal muscle insulin resistance in vitro.

Authors:  S K Pinnamaneni; R J Southgate; M A Febbraio; M J Watt
Journal:  Diabetologia       Date:  2006-10-11       Impact factor: 10.122

4.  Stearoyl-coenzyme A desaturase 1 gene expression increases after pioglitazone treatment and is associated with peroxisomal proliferator-activated receptor-gamma responsiveness.

Authors:  Aiwei Yao-Borengasser; Negah Rassouli; Vijayalakshmi Varma; Angela M Bodles; Neda Rasouli; Resat Unal; Bounleut Phanavanh; Gouri Ranganathan; Robert E McGehee; Philip A Kern
Journal:  J Clin Endocrinol Metab       Date:  2008-08-12       Impact factor: 5.958

5.  Absence of stearoyl-CoA desaturase-1 ameliorates features of the metabolic syndrome in LDLR-deficient mice.

Authors:  Marcia L E MacDonald; Roshni R Singaraja; Nagat Bissada; Piers Ruddle; Russell Watts; Joanna M Karasinska; William T Gibson; Catherine Fievet; Jean E Vance; Bart Staels; Michael R Hayden
Journal:  J Lipid Res       Date:  2007-10-24       Impact factor: 5.922

Review 6.  Role of stearoyl-coenzyme A desaturase in regulating lipid metabolism.

Authors:  Matthew T Flowers; James M Ntambi
Journal:  Curr Opin Lipidol       Date:  2008-06       Impact factor: 4.776

7.  Systems analysis of transcriptional data provides insights into muscle's biological response to botulinum toxin.

Authors:  Kavitha Mukund; Margie Mathewson; Viviane Minamoto; Samuel R Ward; Shankar Subramaniam; Richard L Lieber
Journal:  Muscle Nerve       Date:  2014-03-17       Impact factor: 3.217

8.  Individual stearoyl-coa desaturase 1 expression modulates endoplasmic reticulum stress and inflammation in human myotubes and is associated with skeletal muscle lipid storage and insulin sensitivity in vivo.

Authors:  Andreas Peter; Cora Weigert; Harald Staiger; Fausto Machicao; Fritz Schick; Jürgen Machann; Norbert Stefan; Claus Thamer; Hans-Ulrich Häring; Erwin Schleicher
Journal:  Diabetes       Date:  2009-05-28       Impact factor: 9.461

9.  Gene expression profiling in the type 1 diabetes rat diaphragm.

Authors:  Erik van Lunteren; Michelle Moyer
Journal:  PLoS One       Date:  2009-11-13       Impact factor: 3.240

10.  Significant associations of stearoyl-CoA desaturase (SCD1) gene with fat deposition and composition in skeletal muscle.

Authors:  Zhihua Jiang; Jennifer J Michal; David J Tobey; Tyler F Daniels; Daniel C Rule; Michael D Macneil
Journal:  Int J Biol Sci       Date:  2008-09-25       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.